| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |